Cooperative Agreement U48DP006966
- This Cooperative Agreement award, valued at $871,473.00, was provided by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The award was granted to the District of Columbia Department of Health (DC Health) to support immunization efforts and reduce vaccine-preventable diseases across the District. Key objectives include enhancing immunization program infrastructure, expanding outreach, and leveraging data-driven...
- The Michigan Department of Health and Human Services (MDHHS) was awarded a $3,658,366 Cooperative Agreement from the National Center for Immunization and Respiratory Diseases, a component of the Centers for Disease Control and Prevention (CDC). The award is funded through the Grants to States for Medicaid (CFDA 93.778) program and aims to strengthen vaccine-preventable disease prevention and response efforts in the state of Michigan. Over the five-year period from July 1, 2025 to June 30,...
- This $4,652,515 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Grants to States for Medicaid (CFDA 93.778) program, is funding the Chicago Department of Public Health (CDPH) to strengthen vaccine-preventable disease prevention and response. The funding period is from July 1, 2025 to June 30, 2030. Through this award, CDPH will deliver a range of critical public health services and interventions, including community health worker training, HIV and...
- This $7,018,665 Cooperative Agreement award was provided by the National Center for Immunization and Respiratory Diseases (NCIRD), a division of the Centers for Disease Control and Prevention (CDC), under the CDC's Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program. The award supports the Michigan Department of Health and Human Services (MDHHS) in strengthening the readiness of local and state public health and healthcare to respond to a highly...
- This $344,222.00 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) will support the Virginia Department of Health (VDH) in enhancing vaccine-preventable disease prevention and response efforts across the state. The project period runs from July 1, 2025 to June 30, 2030. Key objectives include bolstering immunization infrastructure, improving disease surveillance, and expanding community...
- The Minnesota Department of Health (MDH) received a $283,951 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will be used to strengthen vaccine-preventable disease prevention and response efforts in Minnesota from July 1, 2025 through June 30, 2030. Key activities include supplying vaccines for children and uninsured/underinsured adults, monitoring immunization rates,...
- The Los Angeles County Department of Public Health was awarded a $165,579 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to support vaccination and immunization efforts in Los Angeles City. The award, which runs from July 1, 2025 to June 30, 2030, aims to expand vaccine coverage, increase adult vaccination rates, and enhance the response to vaccine-preventable diseases in the region. Key activities...
- The Centers for Disease Control and Prevention (CDC) awarded a $427,929 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Pennsylvania Department of Health (PADOH) to strengthen vaccine-preventable disease prevention and response. The award will fund the PADOH's immunization program, which includes the Bureau of Immunizations, to perform activities such as improving immunization information systems, enhancing field services, and supporting...
- This federal Cooperative Agreement award of $4,052,881.00 was provided by the Centers for Disease Control and Prevention (CDC), through the Immunization Cooperative Agreements (CFDA 93.268) program, to the Massachusetts Department of Public Health (MDPH). The award aims to strengthen vaccine-preventable disease prevention and response efforts across Massachusetts. Key services to be delivered through this 5-year award, which begins on July 1, 2025, include purchasing and distributing vaccines,...
- The U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $6,697,775 Cooperative Agreement under CFDA 93.354 - Public Health Emergency Response to the District of Columbia Department of Health (DC Health). The award, effective January 17, 2025 through January 16, 2026, will enable DC Health - in coordination with key Emergency Support Function #8 partners - to enhance the District's overall ability to prepare for, respond to, and recover from...
This Cooperative Agreement award of $224,701.00 from the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program, CFDA 93.323, will support the development and implementation of a training program to increase vaccination rates in early childcare and education centers. The program, titled "BREATHE WELL," aims to enhance public health agencies' capabilities in detecting, responding to, preventing, and controlling infectious diseases. The University of Michigan, as the primary awardee, will leverage its extensive academic infrastructure and interdisciplinary expertise to deliver this cutting-edge solution for the CDC. The project period runs from September 30, 2025, through September 29, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $224.7k | 9/23/25 |